Germany’s BioNTech Settles With US Agency, UPenn Over COVID Vaccine Royalties
Insurance Journal - Dec 27, 2024
BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania over the payment of royalties related to its COVID-19 vaccine, the company said in filings. The German company, which partners …...
Recommended Articles
Posted: Jul 03, 2025
A fire that shut London’s Heathrow airport in March, stranding thousands of people, was caused...
Posted: Jul 03, 2025
For insurance producers, changing agencies might be as simple as signing a waiver. Other times, a pr...
Posted: Jul 03, 2025
Ki Appoints Ex-PartnerRe Exec Bonneau as Chair Ki, the algorithmically powered Lloyd’s digital...